The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
966
January 19, 1996
View Complete Issue         Table of Contents 2019 
Immune Globulin IV for Prevention of RH Isoimmunization and for Treatment of ITP
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Immune Globulin IV for Prevention of RH Isoimmunization and for Treatment of ITP
January 19, 1996 (Issue: 966)
immune globulin (human) has been available for many years in an intramuscular (IM) formulation for prevention of Rh isoimmunization in pregnant Rh-negative women (Medical Letter, 16:3, 1974). Recently, the US Food and Drug Administration (FDA) ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Immune Globulin IV for Prevention of RH Isoimmunization and for Treatment of ITP
Article code: 966b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.